Ogivri
List of products in the National Drug Code with proprietary name ogivri. Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
67457-847 | Ogivri | Trastuzumab | Kit | Mylan Institutional Llc | Human Prescription Drug | |
67457-991 | Ogivri | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Mylan Institutional Llc | Human Prescription Drug |
83257-001 | Ogivri | Trastuzumab-dkst | Injection, Powder, Lyophilized, For Solution | Intravenous | Biocon Biologics Inc. | Human Prescription Drug |
83257-003 | Ogivri | Trastuzumab-dkst | Injection, Powder, Lyophilized, For Solution | Intravenous | Biocon Biologics Inc. | Human Prescription Drug |
83257-004 | Ogivri | Trastuzumab-dkst | Kit | Biocon Biologics Inc. | Human Prescription Drug |